Diantha Duvall
CIK 1696784 · CFO · last filed 2026-03-23
Diantha Duvall is a CFO who has filed 25 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing, for CRIS, was dated Mar 23, 2026. Across all open-market trades the lifetime net is −$55.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $32.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$32.7K
3
25
-$55.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRIS | CFO | 77,707 | $0.42 | $32.7K | $0 | 6 | 2026-03-23 |
| GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | CHIEF FINANCIAL OFFICER | 75,388 | $0.00 | $45 | -$6.3K | 8 | 2022-06-03 |
| Bioverativ Inc. (BIVV) Delisted | Chief Accounting Officer | 0 | — | — | -$49.5K | 11 | 2018-03-08 |
Recent Filings
25 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-23 | CRIS | Conv (C) | +66,666 | $0 | EDGAR |
| 2026-03-18 | CRIS | Grant (A) | — | $0 | EDGAR |
| 2025-05-22 | CRIS | Grant (A) | — | $0 | EDGAR |
| 2025-01-30 | CRIS | Grant (A) | — | $0 | EDGAR |
| 2024-05-23 | CRIS | Grant (A) | — | $0 | EDGAR |
| 2023-01-24 | CRIS | Grant (A) | — | $0 | EDGAR |
| 2022-06-03 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Sell (S) | −1,355 | -$81 | EDGAR |
| 2022-05-26 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Sell (S) | −24,407 | -$1.9K | EDGAR |
| 2022-04-05 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Sell (S) | −963 | -$1.2K | EDGAR |
| 2022-03-17 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Mixed | +34,627 | -$3.2K | EDGAR |